| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053044 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | CA2375908C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/30/2006 | CA2267103C Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof |
| 05/30/2006 | CA2251132C Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/26/2006 | WO2006055638A2 Fully human monoclonal antibodies to il-13 |
| 05/26/2006 | WO2006054793A1 Benzofuran compound and pharmaceutical composition containing the same |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054162A1 Azabicyclic muscarinic receptor antagonists |
| 05/26/2006 | WO2006054135A1 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006007881A3 New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 05/26/2006 | WO2005080338A3 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins |
| 05/26/2006 | CA2587903A1 Fully human monoclonal antibodies to il-13 |
| 05/26/2006 | CA2586395A1 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111426 Indole-3-sulphur derivaties |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111344 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111278 TFF peptides |
| 05/25/2006 | US20060110473 Composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659117A1 2-naphthylimino-1,3-thiazine derivative |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658860A1 Drug compositions comprising anticholinergics and EGFR kinase inhibitors |
| 05/24/2006 | EP1658851A1 Anti-asthmatic combinations comprising surface active phospholipids |
| 05/24/2006 | EP1658291A2 Substituted 8-heteroaryl xanthines |
| 05/24/2006 | EP1658063A1 Advantageous combinations for inhalation of nacystelyn and bronchodilators |
| 05/24/2006 | EP1539723B1 Novel use of benzothiazole derivatives |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1374881B1 A pharmaceutical preparation for asthma |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1242102B1 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 05/24/2006 | EP1104288B1 Orally disintegrable tablet forming a viscous slurry |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | DE202006004916U1 Caring and healing ointment, for the treatment of dry and inflamed nasal mucous membrane, comprises rapeseed oil, thistle oil, olive oil, ointment base and emulsifiers, e.g. soy lecithin |
| 05/24/2006 | DE102004056579A1 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid Inhaled anticholinergic drugs containing a new, salmeterol, and a steroid |
| 05/24/2006 | DE102004056578A1 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid Inhaled medicines containing a new anticholinergic, formoterol and a steroid |
| 05/24/2006 | CN1777600A 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777580A Prostaglandin derivatives |
| 05/24/2006 | CN1775794A Azitromycin double salts and their preparing method and use |
| 05/24/2006 | CN1775287A SARS influenza bivalent combined vaccine and its preparing process |
| 05/24/2006 | CN1775282A Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method |
| 05/24/2006 | CN1775274A Cough-relieving sputum-resolving medicinal composition and preparing method |
| 05/24/2006 | CN1775273A Liangge preparation and new preparing method |
| 05/24/2006 | CN1775270A Yuying preparation and new preparing method |
| 05/24/2006 | CN1775269A Qianjin sputum-resolving preparation and new preparing method |
| 05/24/2006 | CN1775266A Qianjin cough-relieving preparation and new preparing method |
| 05/24/2006 | CN1775265A Shenmai-dihuang preparation and new preparing method |
| 05/24/2006 | CN1775262A Guifu-Dihuang preparation and preparing method |
| 05/24/2006 | CN1775259A Anemarrhena preparation and new preparation method |
| 05/24/2006 | CN1775248A Dried tangerine peel sputum-resolving preparation and new preparing method |
| 05/24/2006 | CN1775244A Blood-cleaning detoxifying formulation and new preparing method |
| 05/24/2006 | CN1775242A Medicine composition with bacteria-inhibiting anti-inflammation function, its preparing method and use |
| 05/24/2006 | CN1775233A Red-rooted-salvia-root chuanxiong-rhizome azine injecta, its preparation method and use |
| 05/24/2006 | CN1775222A Saline solution for treating nasal cavity disease and its application device |
| 05/24/2006 | CN1775213A Dextromethorphan hydrobromide nose drops |
| 05/24/2006 | CN1775088A Malt sugar |
| 05/24/2006 | CN1775056A Tea of folium mori and chrysanthemum and its preparing method |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1257186C Interferon gamma polypeptide variants |
| 05/24/2006 | CN1257162C SARS coronavirus 3CL protease inhibitor and its use |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1256983C Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 05/24/2006 | CN1256970C Naristillae for curing rhinopathy |
| 05/24/2006 | CN1256962C Medicine for treating throat disease and its preparation method |
| 05/24/2006 | CN1256961C Tea and tea mate for rhinitis |
| 05/24/2006 | CN1256959C Rhinitis treating medicinal cream |
| 05/24/2006 | CN1256956C Medicament for treating acute and chronic rhinitis and nasosinusitis |
| 05/24/2006 | CN1256954C Argyi leaf oil dripping pills and its preparation process |
| 05/24/2006 | CN1256942C Application of dihydromyricetrin |
| 05/24/2006 | CN1256905C New method for inhibiting flu and preventing SARS |
| 05/23/2006 | US7049455 Process for producing shogaols and intermediates for the synthesis thereof |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049345 Fat-binding polymers |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7048933 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |